Copley Phillip, Kirkman Matthew A, Thompson Dominic, James Greg, Aquilina Kristian
Department of Neurosurgery, Great Ormond Street Hospital for Children NHS Trust, WC1N 3JH, London, UK.
Childs Nerv Syst. 2018 Feb;34(2):257-266. doi: 10.1007/s00381-017-3524-9. Epub 2017 Jul 17.
Less than 0.5% of arachnoid cysts are intraventricular in origin. We review our experience with endoscopic surgery for intraventricular arachnoid cysts in children.
This is a retrospective review of children with intraventricular arachnoid cysts who underwent surgery between 2005 and 2016. Clinical notes and imaging were reviewed.
Twenty-nine patients with endoscopically treated intraventricular arachnoid cysts were identified (M/F = 17:12; median age = 1.47 years, range = 7 days-13 years). All had hydrocephalus at presentation, many had symptoms/signs of raised intracranial pressure, and five (17%) were asymptomatic. Cysts were treated with fenestration into the ventricle alone (ventriculocystostomy [VC], n = 14), fenestration into the ventricle and cisternostomy (ventriculocystostomy plus cisternostomy [VC + C], n = 14), or endoscopic third ventriculostomy alone (n = 1). Six (21%) patients experienced transient and/or conservatively managed complications. Further surgery was required in 12 (41%). Revision-free survival was significantly shorter with VC compared to VC + C (log rank p = 0.049), and the majority of VC/VC + C revisions (n = 8 of 11, 73%) were required within 6 months of initial endoscopic surgery. One (3%) patient died during follow-up, from unrelated pathology. After a median follow-up of 67.5 months in survivors (range = 5.5-133.5 months), 24 (83%) cases were clinically and radiologically stable without a shunt in situ.
Endoscopic fenestration is safe and effective in most intraventricular arachnoid cysts. Additional cisternostomy at the time of cyst fenestration into the ventricle significantly improved revision-free survival in our cohort. Endoscopic surgery should be the first-line therapy when considering intervention for symptomatic intraventricular arachnoid cysts and for asymptomatic cysts increasing in size on serial imaging.
起源于脑室的蛛网膜囊肿不到0.5%。我们回顾了我们对儿童脑室蛛网膜囊肿进行内镜手术的经验。
这是一项对2005年至2016年间接受手术的脑室蛛网膜囊肿患儿的回顾性研究。回顾了临床记录和影像学资料。
确定了29例接受内镜治疗的脑室蛛网膜囊肿患者(男/女=17:12;中位年龄=1.47岁,范围=7天至13岁)。所有患者就诊时均有脑积水,许多患者有颅内压升高的症状/体征,5例(17%)无症状。囊肿仅通过造瘘进入脑室进行治疗(脑室囊肿造瘘术[VC],n=14),造瘘进入脑室并进行脑池造瘘(脑室囊肿造瘘术加脑池造瘘术[VC+C],n=14),或仅进行内镜下第三脑室造瘘术(n=1)。6例(21%)患者出现短暂和/或保守处理的并发症。12例(41%)患者需要进一步手术。与VC+C相比,VC的无翻修生存率显著缩短(对数秩检验p=0.049),大多数VC/VC+C翻修手术(11例中的8例,73%)在初次内镜手术后6个月内进行。1例(3%)患者在随访期间因无关病理死亡。幸存者中位随访67.5个月(范围=5.5至133.5个月)后,24例(83%)病例在临床上和影像学上稳定,无需原位分流。
内镜下造瘘术对大多数脑室蛛网膜囊肿是安全有效的。在囊肿造瘘进入脑室时附加脑池造瘘术可显著提高我们队列中的无翻修生存率。当考虑对有症状的脑室蛛网膜囊肿和在系列影像学检查中增大的无症状囊肿进行干预时,内镜手术应作为一线治疗方法。